Earlier insights for fertility and pregnancy.
From fertility through pregnancy, Miora helps women and their providers understand risk earlier, personalize care, and make informed decisions before complications develop.
Built around your pregnancy timeline, not just a single test
Every stage carries its own risks. Miora is building toward earlier insight at each one, from Trimester 0 to Trimester 4 (T0 - T4).
Labor & Delivery
Delivery-readiness insight.
Postpartum
Recovery & long-term outcome tracking.
Built with clinical and scientific rigor. Trained on NIH-funded research, developed with physician-scientist leadership in maternal and metabolic health.
Earlier care is gaining momentum.
Growing interest from patients and providers who want answers earlier in the journey, not just after something goes wrong.
Join NowChoose your experience
Understand your own health, sooner
At-home testing across pregnancy, gut, and vaginal health, with reports built for you and your provider.
For Patients →Bring earlier insight into your practice
Clinical workflows, portal access, and research partnership opportunities for care teams.
For Providers →Sign up for updates
Be the first to know as new stages of the journey open up.
Frequently asked questions
Quick answers about Miora, our tests, and how microbiome insight supports earlier care.
Miora Health is a biotechnology company using microbiome science and AI to set a new standard of care. Miora develops at-home, non-invasive tests powered by next-generation sequencing and proprietary AI models that reveal insight not available through traditional testing across fertility, pregnancy risk, including gestational diabetes and preterm birth, gut health, and vaginal health.
Miora's mission is to shift health care from reactive treatment to earlier understanding, proactive intervention, and stronger long-term outcomes.
Miora tests are completed at home, no long clinic visits. They are non-invasive, no blood draws.
The microbiome plays a role in areas of health including pregnancy, vaginal health, and gastrointestinal function. Research shows that shifts in microbial communities are associated with conditions such as gestational diabetes, vaginal infections, and digestive disorders. Evaluating these patterns can provide insight into physiological changes that traditional testing may not detect.
